Tablet
ABIRATERONE SANDOZ TABLETS 250MG
Summary
ABIRATERONE SANDOZ TABLETS 250MG — Tablet containing abiraterone acetate. Hong Kong Registration No. HK-68036. Certificate Holder: SANDOZ HONG KONG LIMITED. Date of Registration: 29 Nov, 2023.
Product NameABIRATERONE SANDOZ TABLETS 250MG
Registration No.HK-68036
Certificate HolderSANDOZ HONG KONG LIMITED
Holder AddressUNIT 2901, NO. 28 STANLEY STREET, CENTRAL, HONG KONG
Ingredientsabiraterone acetate
Dosage FormTablet
Legal ClassificationPart 1, Schedule 1 & Schedule 3 Poison
Sale RequirementPrescription only Medicines
Date of Registration29 Nov, 2023
ATC codesL02BX03
ATC Classification
ATC level 1
L Antineoplastic and Immunomodulating Agents
All ATC groupsL02
本頁為藥物資料查詢工具,並非藥物廣告、推廣或醫療建議。所有資料取自香港特別行政區衞生署藥物辦公室之公開資料,僅供參考;一切以藥物辦公室官方公布為準。 本頁不提供任何療效、適應症或治療用途之陳述。用藥前請諮詢醫生或註冊藥劑師。 本網站遵守香港法例第 231 章《不良廣告(醫藥)條例》之規管。